Advanced Analytical Technologies
Advanced Analytical Technologies develops automated capillary electrophoresis systems and consumables for nucleic acid and protein QC, serving life science research labs, clinical diagnostics and biopharma QC groups, and biopharma/CRO/CDMO customers.
- Company typePublic
- Founded1999
- HeadquartersAnkeny, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Advanced Analytical Technologies does
Advanced Analytical Technologies develops, manufactures, and markets high-throughput, fully automated nucleic acid and genetic analysis systems, with a portfolio of ten automated electrophoresis instruments that span ultralow to ultrahigh throughput and are anchored on capillary electrophoresis technology. The product families — Bioanalyzer, Fragment Analyzer, TapeStation, Femto Pulse, ProteoAnalyzer, ZAG DNA Analyzer, and Oligo Pro II — are each bundled with dedicated kits, reagents, consumables (capillary arrays, ScreenTapes), instrument control software, and accessories, creating a platform-plus-modules architecture that supports DNA, RNA, protein, and oligonucleotide analysis for cfDNA, gDNA, NGS, and PCR sample quality control workflows. The company serves three primary customer segments: life science research laboratories, clinical diagnostics and biopharma QC labs, and biopharma/CRO/CDMO organizations requiring regulated analytical methods and GMP-grade consumables.
Revenue is generated through a classic razor-blade model: capital equipment (instruments) is sold upfront under quote-based enterprise contracts, while recurring revenue comes from the associated kits, reagents, capillary arrays, and ScreenTape consumables that represent 65-70% of the broader market's revenue mix. Distribution is executed via direct enterprise field sales, an online storefront, and regional sales contacts worldwide, with adjacent revenue from Agilent University training, CrossLab service plans, and post-sale community support. The addressable US DNA sequencing electrophoresis systems market is projected at USD 1.3-1.6 billion in 2026 growing to USD 2.0-2.5 billion by 2035 (4.5-6.0% CAGR), with capillary electrophoresis systems holding a 70-75% share of that market.
Strategic posture is multi-pronged: inorganic expansion via acquisitions (Biocare for digital pathology, Biovectra for GMP oligonucleotide manufacturing, e-MSion for LC-MS, Polymer Standards Service for chromatography standards, and Sigsense for lab business intelligence) broadens the analytical instrument ecosystem beyond the core electrophoresis franchise, while vertical emphasis on biopharma, CROs, and CDMOs targets regulated GMP-compliant analytical workflows. Note: the source data contains material inconsistencies — firmographics describe AATI as a private entity founded in 1998 with 101-250 employees in Ankeny, USA, while other blocks describe a publicly traded Agilent Technologies (NYSE: A) incorporated in Delaware with headquarters in Santa Clara. This analysis treats AATI as the named subject while grounding product, market, and moat evidence in the described automated electrophoresis portfolio.
Advanced Analytical Technologies firmographics
Firmographics- Name
- Advanced Analytical Technologies
- Legal name
- Agilent Technologies, Inc.
- Website
- https://aati-us.com
- Company type
- Public
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Advanced Analytical Technologies develops automated capillary electrophoresis systems and consumables for nucleic acid and protein QC, serving life science research labs, clinical diagnostics and biopharma QC groups, and biopharma/CRO/CDMO customers.
- Ownership category
- akta.pro rank
Where Advanced Analytical Technologies is headquartered
LocationHeadquarters
- HQ city
- Ankeny
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Advanced Analytical Technologies business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Automated Electrophoresis Instruments and Consumables: Razor-blade business model typical of life science tools industry. Instruments sold as capital equipment, with recurring revenue from consumables (kits, reagents, capillary arrays, ScreenTapes) for sample quality control applications including cfDNA, gDNA, NGS, and PCR workflows
- Market Analysis - Consumables Dominance: In the DNA sequencing electrophoresis systems market, consumables account for 65-70% of total market revenue, with capillary electrophoresis systems dominating at 70-75% market share
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| One time/ perpetual license | Multi-year contract | Multiple instrument tiers from ultralow to ultrahigh throughput |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels6 records
Advanced Analytical Technologies product offering
Product offeringCore offering
Advanced Analytical Technologies develops, manufactures, and markets high-throughput, fully-automated nucleic acid and genetic analysis systems based on capillary electrophoresis technology. The company offers a portfolio of automated electrophoresis instruments covering ultralow to ultrahigh throughput configurations, sold alongside specialized kits, reagents, dedicated software, and consumable/accessory components for DNA, RNA, and protein sample quality control.
Product overview
The Automated Electrophoresis portfolio is a platform-plus-modules architecture consisting of ten automated electrophoresis instruments along with associated kits, reagents, software, and accessories. The core instrument families include: Bioanalyzer Systems for high-resolution electrophoresis of DNA, RNA, and proteins; Fragment Analyzer Systems for efficient nucleic acid QC; TapeStation Systems for DNA and RNA sample QC; Femto Pulse Systems for quantifying and sizing DNA/RNA samples; ProteoAnalyzer Systems for automated capillary electrophoresis of proteins; ZAG DNA Analyzer Systems for high-throughput fragment screening; and Oligo Pro II Systems for oligonucleotide purity analysis. Each system is supported by specialized kits and reagents (DNA, RNA, or protein analysis kits), dedicated software, and consumable/accessory components. The portfolio is designed for variable throughputs from ultralow to ultrahigh and serves applications including cfDNA, gDNA, NGS, and PCR sample quality control.
Differentiator
Problem solved
Functional benefit
Brands
- Bioanalyzer: High-resolution automated electrophoresis system for DNA, RNA, and protein samples
- Fragment Analyzer
- TapeStation
- Femto Pulse
- ProteoAnalyzer
- ZAG DNA Analyzer
- Oligo Pro II
- Dako Academy
- CrossLab
- Agilent University
- iLab
Products and services
- Bioanalyzer Systems High-resolution automated electrophoresis system for DNA, RNA, and protein sample analysis, including the core instrument along with associated kits, reagents, software, and accessories.
- Fragment Analyzer Systems Automated electrophoresis system for accurate, efficient, and reliable QC analysis of nucleic acids, including DNA analysis kits, RNA kits, capillary arrays, software, and parts & accessories.
- TapeStation Systems Automated electrophoresis solution for DNA and RNA sample QC based on ScreenTape technology, including instruments, ScreenTape reagents, software, and parts & accessories.
- Femto Pulse Systems Automated system to quantify, qualify, and size DNA and RNA samples with accuracy and precision using capillary array technology, including DNA and RNA analysis kits, capillary arrays, software, and parts & accessories.
- ProteoAnalyzer Systems Automated capillary electrophoresis system specifically designed for protein analysis.
- ZAG DNA Analyzer Systems Automated capillary electrophoresis system for high-throughput screening of DNA fragments.
- Oligo Pro II Systems Fast purity analysis system for single-stranded RNA and DNA oligonucleotides.
Quantifiable outcome
- Capillary electrophoresis systems dominate with 70-75% market share in US DNA sequencing electrophoresis market
- +1 more outcomes
Companies that use Advanced Analytical Technologies
Customer profileSegments3 records
Ideal customer profiles1 record
Advanced Analytical Technologies technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Advanced Analytical Technologies partnerships and signals
Strategic signalScale indicators4 records
Recent moves6 records
Expansion highlights5 records
Advanced Analytical Technologies competitors and assessment
Company assessmentMarket position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Customer concentration
Advanced Analytical Technologies social profiles
Digital presenceAdvanced Analytical Technologies financial estimates
Financial estimateRevenue estimate
Valuation estimate
Advanced Analytical Technologies leadership team
Management profileNumber of profiles
Profiles4 records
Advanced Analytical Technologies subsidiaries and ownership
Company hierarchySubsidiaries5 records
Advanced Analytical Technologies funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Advanced Analytical Technologies M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Advanced Analytical Technologies
What does Advanced Analytical Technologies do?
Advanced Analytical Technologies develops, manufactures, and markets high-throughput, fully-automated nucleic acid and genetic analysis systems based on capillary electrophoresis technology. The company offers a portfolio of automated electrophoresis instruments covering ultralow to ultrahigh throughput configurations, sold alongside specialized kits, reagents, dedicated software, and consumable/accessory components for DNA, RNA, and protein sample quality control.
Is Advanced Analytical Technologies a public or private company?
Advanced Analytical Technologies is a public company. It is classified as unknown and is currently operating.
When was Advanced Analytical Technologies founded?
Advanced Analytical Technologies was founded in 1999. It employs 101 to 250 people.
Where is Advanced Analytical Technologies based?
Advanced Analytical Technologies is headquartered in Ankeny, United States, in the North America region.
How does Advanced Analytical Technologies make money?
Two revenue lines are on record. Automated Electrophoresis Instruments and Consumables are the primary driver. The others are market Analysis - Consumables Dominance.
Does Advanced Analytical Technologies have an API?
No public API is recorded for Advanced Analytical Technologies.